ARETEIA THERAPEUTICS
Areteia Therapeutics is a biotechnology company committed to putting asthma patients in better control of their disease. The company was spun out of Pennsylvania-based Knopp, which published results from its phase 2 clinical trial last year that showed its oral drug candidate could reduce the count of blood eosinophil, which is an indication of improving lung function and is found in several asthma-related treatments.
ARETEIA THERAPEUTICS
Industry:
Biotechnology Health Care Life Science Therapeutics
Founded:
2022-01-01
Website Url:
http://www.areteiatx.com
Status:
Active
Email Addresses:
[email protected]
Total Funding:
350 M USD
Current Advisors List
Current Employees Featured
Investors List
Saturn Partners
Saturn Partners investment in Series A - Areteia Therapeutics
Sanofi
Sanofi investment in Series A - Areteia Therapeutics
Access Biotechnology
Access Biotechnology investment in Series A - Areteia Therapeutics
Population Health Partners
Population Health Partners investment in Series A - Areteia Therapeutics
GV
GV investment in Series A - Areteia Therapeutics
Maverick Capital
Maverick Capital investment in Series A - Areteia Therapeutics
ARCH Venture Partners
ARCH Venture Partners investment in Series A - Areteia Therapeutics
Bain Capital Life Sciences
Bain Capital Life Sciences investment in Series A - Areteia Therapeutics
Official Site Inspections
http://www.areteiatx.com Semrush global rank: 7.16 M Semrush visits lastest month: 585
- Host name: 104.26.1.205
- IP address: 104.26.1.205
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
